About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
In this video from a session at the United Nations’ 2020 Science, Technology, and Innovation (STI) conference, Prof. Ada Yonath speaks about COVID: its makeup, how it compares with other viruses, possible avenues of treatment, and challenges.
May 21, 2020
REHOVOT, ISRAEL—May 19, 2020—Is the wanton killing of cells in autoimmune disease a case of mistaken identity, or does it arise from an important physiological service? The first is the commonly accepted view – that autoimmune attack is a sort of mistake.
May 19, 2020
The Times of India writes about why young Indian scientists love Weizmann and Israel, including “a perfect mix” of academic excellence, warm culture, and natural beauty.
May 18, 2020
Israel21C reports on research by Prof. Ido Amit’s lab showing why COVID makes some people much sicker than others: an immune system malfunction that “represents the real mystery of coronavirus.”
May 17, 2020
Dr. Nir London discusses the “COVID Moonshot” project in this videoconference. The global initiative, which currently includes nine partners, aims to develop a “cheap and safe” antiviral treatment for COVID on a much faster timeline than traditional drug discovery.
May 17, 2020
The Jerusalem Post reports on an Israeli team – including the Weizmann Institute – that was just named a finalist for a NASA mission to Triton, one of Neptune’s moons.
May 15, 2020
“A Window to the Campus” is a new video series from the Weizmann Institute of Science. In the first video, “Back to Routine,” we find that the lush campus is deceptively quiet...
May 15, 2020
May is Skin Cancer Awareness Month, and Israel21C reports on research advances – including by Prof. Yardena Samuels.
May 14, 2020
Prof. Ido Amit’s team is showing why COVID affects people so differently, reports The Times of Israel. The work could help pharmaceutical firms develop drugs by “providing a ‘target’ in the body for intervention.”
May 14, 2020
©2020 American Committee for the Weizmann Institute of Science